tibsovopro.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
User-agent: * Disallow: /unsubscribe.html Disallow: /search.html Sitemap: | ||
Meta Tags
| Title | TIBSOVO® (ivosidenib tablets) an IDH1 |
| Description | FIRST-IN-CLASS TARGETED INHIBITOR OF TIBSOVO® treatment for patients with Acute Myeloid Leukemia or Cholangiocarcinoma. See full indications, prescribing information, & boxed |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 54.91.6.89 |
| Location | United States |
Related Websites
| Site | Rank |
More to Explore
tibsovopro.com Valuation
|
US$5,032,536
Last updated: 2023-05-10 20:48:37
tibsovopro.com has Semrush global rank of 2,103,175. tibsovopro.com has an estimated worth of US$ 5,032,536, based on its estimated Ads revenue. tibsovopro.com receives approximately 580,678 unique visitors each day. Its web server is located in United States, with IP address 54.91.6.89. According to SiteAdvisor, tibsovopro.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$5,032,536 |
| Daily Ads Revenue | US$4,646 |
| Monthly Ads Revenue | US$139,363 |
| Yearly Ads Revenue | US$1,672,351 |
| Daily Unique Visitors | 38,712 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| tibsovopro.com. | A | 7199 | IP: 54.91.6.89 |
| tibsovopro.com. | NS | 86400 | NS Record: ns6.markmonitor.com. |
| tibsovopro.com. | NS | 86400 | NS Record: ns2.markmonitor.com. |
| tibsovopro.com. | NS | 86400 | NS Record: ns3.markmonitor.com. |
| tibsovopro.com. | NS | 86400 | NS Record: ns1.markmonitor.com. |
| tibsovopro.com. | NS | 86400 | NS Record: ns7.markmonitor.com. |
| tibsovopro.com. | NS | 86400 | NS Record: ns5.markmonitor.com. |
| tibsovopro.com. | NS | 86400 | NS Record: ns4.markmonitor.com. |
| tibsovopro.com. | TXT | 86400 | TXT Record: google-site-verification=PvIHSyTZfqZ3-fXHObb9G8HSr-dbrjh_pU1G3Toj-OU |
HtmlToTextCheckTime:2023-05-10 20:48:37
| × You are now leaving the healthcare professional website. Do you wish to leave this site? Yes No This site is intended for U.S. healthcare professionals. For Patients Important Safety Information Prescribing Information/Medication Guide MENU FIRST-IN-CLASS TARGETED INHIBITOR OF mIDH1, an early driver mutation in acute myeloid leukemia (AML) and cholangiocarcinoma (CCA) . 1–3 Acute myeloid leukemia › Newly diagnosed: TIBSOVO + azacitidine efficacy › TIBSOVO monotherapy efficacy › R/R efficacy › Safety › Dosing › Cholangiocarcinoma › Efficacy › Safety › Dosing › For patients › TIBSOVO ® (ivosidenib tablets) is a once-daily, oral differentiation therapy for the treatment of adult patients who have a susceptible IDH1 mutation as detected by an FDA-approved test with 1,2 : Acute myeloid leukemia In combination with azacitidine for newly diagnosed, IC-ineligible AML or as monotherapy for newly diagnosed, IC-ineligible AML and R/R AML 2 Newly diagnosed: TIBSOVO + azacitidine efficacy › |
HTTP Headers
HTTP/1.1 302 Found Server: Cowboy Connection: keep-alive X-Powered-By: Express Location: https://tibsovopro.com/ Vary: Accept, Accept-Encoding Content-Type: text/plain; charset=utf-8 Content-Length: 45 Date: Wed, 03 Nov 2021 10:52:06 GMT Via: 1.1 vegur HTTP/1.1 200 OK Server: Cowboy Connection: keep-alive X-Powered-By: Express Access-Control-Allow-Origin: * Content-Type: text/html; charset=utf-8 Content-Length: 79823 Etag: W/"137cf-Z2gR6MciKnjFQ7QnXkfzzixog7E" Vary: Accept-Encoding Date: Wed, 03 Nov 2021 10:52:06 GMT Via: 1.1 vegur |
tibsovopro.com Whois Information
Domain Name: TIBSOVOPRO.COM Registry Domain ID: 2210602229_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.markmonitor.com Registrar URL: http://www.markmonitor.com Updated Date: 2021-04-13T19:43:42Z Creation Date: 2018-01-08T20:26:10Z Registry Expiry Date: 2024-01-08T20:26:10Z Registrar: MarkMonitor Inc. Registrar IANA ID: 292 Registrar Abuse Contact Email: abusecomplaints@markmonitor.com Registrar Abuse Contact Phone: +1.2083895740 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS1.MARKMONITOR.COM Name Server: NS2.MARKMONITOR.COM Name Server: NS3.MARKMONITOR.COM Name Server: NS4.MARKMONITOR.COM Name Server: NS5.MARKMONITOR.COM Name Server: NS6.MARKMONITOR.COM Name Server: NS7.MARKMONITOR.COM DNSSEC: unsigned >>> Last update of whois database: 2021-10-05T10:05:10Z <<< |